Patents Assigned to Malaghan Institute of Medical Research
  • Synthetic molecules having immune activity
    Patent number: 7989602
    Abstract: The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosaccharide) activity, for use in the treatment and prevention of inflammatory or immune cell mediated diseases or disorders.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: August 2, 2011
    Assignees: The Malaghan Institute of Medical Research, University of Otago, Agresearch Limited
    Inventors: Gurmit Singh-Gill, David Samuel Larsen, Jeremy David Jones, Wayne Bruce Severn, Jacquie Lucille Harper, Gavin Painter
  • Anti-inflammatory compounds
    Patent number: 7807668
    Abstract: Compounds of formula (I) or formula (II) have anti-inflammatory activity and comprise a new class of NSAIDs. The compounds are useful for treating inflammatory diseases or disorders. The invention also provides pharmaceutical compositions containing these compounds, as well as methods of treating inflammatory diseases or disorders using compounds of formula (III) or formula (IV).
    Type: Grant
    Filed: September 16, 2005
    Date of Patent: October 5, 2010
    Assignees: New Zealand Institute for Crop & Food Research Limited, National Institute of Water and Atmospheric Research Limited, Malaghan Institute of Medical Research
    Inventors: William Alexander Denny, Brent Raymond Copp, Allison Norrie Pearce, Michael Vivian Berridge, Jacquie Lucille Harper, Nigel Brian Perry, Lesley Larsen, Colette Amirah Godfrey
  • Method of using a vaccine
    Publication number: 20030138436
    Abstract: This invention is directed to methods of preventing or reducing the severity of asthma or the risk of development of same in an individual. The method relies on administration to the airways of the individual of an immunologically effective dose of a mycobacterium based vaccine. The mycobacteria are effective in inducing a Th1 type immune response in the individual.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 24, 2003
    Applicant: The Malaghan Institute of Medical Research
    Inventors: Graham Stephen Le Gros, Charles Richard William Beasley, John William Holloway, Klaus Erb
  • Method of using a vaccine
    Patent number: 6569436
    Abstract: This invention is directed to methods of preventing or reducing the severity of asthma or the risk of development of same in an individual. The method relies on administration to the airways of the individual of an immunologically effective dose of a mycobacterium based vaccine. The mycobacteria are effective in inducing a Thl type immune response in the individual.
    Type: Grant
    Filed: October 5, 1998
    Date of Patent: May 27, 2003
    Assignee: The Malaghan Institute of Medical Research
    Inventors: Graham Stephen Le Gros, Charles Richard William Beasley, John William Holloway, Klaus Erb